aod9604 fda approval status 2025 AOD-9604 5mg Peptide Upcoming FDA Decisions - February

Tirzepatide Known by the brand names Mounjaro and Zepbound , tirzepatide is FDA-approved for type 2 diabetes and used off-label for weight loss

Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects

Abdominal or stomach pain difficulty breathing swelling of your face, lips, tongue, or throat Diarrhea While there is some side effect of gaining weight but with its lack of quality research, B12 shots are being offered at some clinics for a weight-loss program that provides more energy and boosts metabolism, helping shed unwanted pounds

Changes in body composition can affect insulin sensitivity independently